Skip to content

Clinical trials

Phase 3 Prostatic Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 3 Country / region: United States Clear all

263 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20017
20028
200310
20047
200513
200611
200712
20089
200913
20107
201110
20127
20133
201410
20155
20165
20179
20187
20196
202013
202113
20225
202311
202410
202514
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed143
Active, not recruiting42
Recruiting33
Terminated30
Unknown status8
Withdrawn5
Not yet recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Radiation Therapy Oncology Group17
Alliance for Clinical Trials in Oncology15
AstraZeneca11
Pfizer9
Memorial Sloan Kettering Cancer Center8
Ferring Pharmaceuticals7
M.D. Anderson Cancer Center7
SWOG Cancer Research Network7
Novartis Pharmaceuticals6
Sanofi6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms263
Neoplasms18
Neoplasm Metastasis15
Breast Neoplasms8
Pain7
Lung Neoplasms6
Osteoporosis6
Carcinoma, Non-Small-Cell Lung4
Colonic Neoplasms4
Disease4

Trials

Showing 1 to 25 of 263. Each trial links to its page on Pharma Observatory.

163 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.